Press Releases MegaPro Biomedical Co., Ltd

Equities

End-of-day quote Taipei Exchange Other stock markets 23:00:00 26/05/2024 BST			5-day change	1st Jan Change
22.95 ^TWD	-0.43%		-4.57%	-5.75%

2022	Megapro Biomedical Co., Ltd Successfully Completes the Biological Evaluations of Iop as Vaccine Adjuvant T Cell Mediated Immunity Is Substantially Enhanced, Improving the Efficacy of Vaccines	CI
2022	Megapro Biomedical Co., Ltd, China Chemical & Pharmaceutical Co., Ltd. and Wellbridge Biotech Ltd. Jointly Establishes an Inhalation Dosage Form Company	CI

No results for this search